Delaby, C, Lehmann, S. Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challenges. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2026; 64(5)DOI:10.1515/cclm-2025-1731. PMID:41630537. IF:3.700(Q1/1D).

Llamas-Velasco, M, Hospital, M, López-Ferrer, A, Herranz, P, Ruíz-Villaverde, R, Mateu, A, García-Latasa, FJ, Rivera, R, Fernández-Freire, LR, Alcazar, ED, Santos, S, Arias, S, Gónzalez-Cantero, A, Belinchon, I, Carretero, G, Ferran, M, Ruiz-Genao, D, Eiris, N, Sahuquillo, A, Mataix, J, Carrascosa, JM, Cueva, PD, Salgado-Boquete, L. Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS). Pharmacy. 2026; 14(3)DOI:10.3390/pharmacy14030063. PMID:42200950. IF:(Q/D).

Cerro-Pardo, I, Picatoste, B, Raposo-Gutiérrez, I, Martos-Folgado, I, Márquez-Gálvez, C, García-García, A, Ortega-Villanueva, L, Mur, SM, Robles-Vera, I, Escolà-Gil, JC, Núñez, E, Sancho, D, Lindholt, J, Vázquez, J, Blanco-Colio, LM, Ramiro, AR, Martín-Ventura, JL. Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1774396. PMID:42112342. IF:5.900(Q1/2D).

Espinós, JJ, Checa, MA, Villegas-Arbelaez, E, Martínez-Zapata, MJ. Luteinizing hormone activity in ovarian stimulation: comparative efficacy and safety of gonadotropins versus recombinant follicle-stimulating hormone-a systematic review and meta-analysis. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1792900. PMID:42100203. IF:4.600(Q1/3D).